The enzyme 3␤-hydroxysteroid dehydrogenase (3␤-HSD) is a key enzyme in the biosynthesis of steroid hormones. To date, this laboratory has isolated and characterized five distinct 3␤-HSD complementary DNAs (cDNAs) in the mouse (3␤-HSD I through V). These different forms are expressed in a tissue-and developmentally-specific manner and fall into two functionally distinct enzymes. 3␤-HSD I and III, and most likely II, function as dehydrogenase/isomerases, whereas 3␤-HSD IV and V function as 3-ketosteroid reductases. This study describes the isolation, characterization, and tissue-specific expression of a sixth member of this gene family, 3␤-HSD VI. This new isoform functions as an NAD ϩ -dependent dehydrogenase/isomerase exhibiting very low Michaelis-Menten constant (K m ) values for pregnenolone (ϳ0.035 M) and dehydroepiandrosterone (ϳ0.12 M). 3␤-HSD VI is the earliest isoform to be expressed during embryogenesis in cells of embryonic origin at 7 and 9.5 days postcoitum (pc), and is the major isoform expressed in uterine tissue at the time of implantation (4.5 days pc) and continues to be expressed in uterine tissue at 6.5, 7.5, and 9.5 days pc. 3␤-HSD VI is expressed in giant trophoblasts at 9.5 days pc and is expressed in the placenta through day 15.5 pc. In the adult mouse, 3␤-HSD VI appears to be the only isoform expressed in the skin and also is expressed in the testis, but to a lesser extent than 3␤-HSD I. Mouse 3␤-HSD VI cDNA is orthologous to human 3␤-HSD I cDNA. Human type I 3␤-HSD has been shown to be the only isoform expressed in the placenta and skin. The demonstration that mouse 3␤-HSD VI functions as a dehydrogenase/isomerase and is the predominant isoform expressed during the first half of pregnancy in uterine tissue and in embryonic cells suggests that this isoform may be involved in local production of progesterone, which is needed for successful implantation of the blastocyst and/or maintenance of early pregnancy.
the major isoform expressed in uterine tissue at the time of implantation (4.5 days pc) and continues to be expressed in uterine tissue at 6.5, 7.5, and 9.5 days pc. 3␤-HSD VI is expressed in giant trophoblasts at 9.5 days pc and is expressed in the placenta through day 15.5 pc. In the adult mouse, 3␤-HSD VI appears to be the only isoform expressed in the skin and also is expressed in the testis, but to a lesser extent than 3␤-HSD I. Mouse 3␤-HSD VI cDNA is orthologous to human 3␤-HSD I cDNA. Human type I 3␤-HSD has been shown to be the only isoform expressed in the placenta and skin. The demonstration that mouse 3␤-HSD VI functions as a dehydrogenase/isomerase and is the predominant isoform expressed during the first half of pregnancy in uterine tissue and in embryonic cells suggests that this isoform may be involved in local production of progesterone, which is needed for successful implantation of the blastocyst and/or maintenance of early pregnancy. (Endocrinology 138: 1392-1399, 1997) A LL STEROID hormones are derived from cholesterol. A key enzyme in this pathway is 3␤-hydroxysteroid dehydrogenase/isomerase (3␤-HSD). This enzyme catalyzes the conversion of ⌬ 5 -3␤-hydroxysteroids to ⌬ 4 -3-ketosteroids, a reaction that is essential for the biosynthesis of all active steroid hormones, including the adrenal steroid hormones, cortisol, corticosterone, and aldosterone, as well as the gonadal steroid hormones progesterone, testosterone, and estradiol.
Recent reports have provided evidence for the expression of multiple isoforms in humans (1) (2) (3) and rodents (4 -7) . For a classification of the human, mouse, and rat isoforms see Clarke et al. (8) . These isoforms are products of distinct genes and are expressed in a tissue-specific manner. Our laboratory has studied the isoforms expressed in the mouse. To date, we have isolated and characterized five distinct but highly homologous mouse 3␤-HSD complementary DNAs (cDNAs), which are indicated by roman numerals (I-V) in the chronological order in which they have been isolated. The genes encoding the different isoforms are found closely linked on mouse chromosome 3 (9) . The five isoforms not only are expressed in a tissue-specific manner, but also fall into two distinct functional groups. One group, as represented by 3␤-HSD I and III (and most likely II), functions as dehydrogenase/isomerases (10) and is essential for the biosynthesis of active steroid hormones, whereas the other group, represented by IV and V, functions as 3-ketosteroid reductases and appears to be involved in the inactivation of active steroid hormones (6, 7) . 3␤-HSD I in the adult mouse is expressed in the gonads and adrenal glands (5) . 3␤-HSD II and III are expressed in the liver and kidney (5) , with much greater expression of III in the liver than in the kidney. The major site of expression of 3␤-HSD IV is in the proximal tubules of the kidney of male and female mice (6) , with minor expression in the testis (7) . The expression of 3␤-HSD V appears to occur only in the liver of the male mouse, with expression starting during the latter half of pubertal development (7, 11) . This paper describes the isolation and tissue-specific expression of a new isoform, 3␤-HSD VI, which is the major isoform expressed during the first half of pregnancy in cells of embryonic origin and in uterine tissue. 3␤-HSD VI appears to be the only isoform expressed in skin. It is expressed in Leydig cells of the adult testis but to a lesser extent than 3␤-HSD I. Mouse 3␤-HSD VI appears to be orthologous to human 3␤-HSD I, which is expressed in the placenta and skin (3) . The temporal expression of 3␤-HSD VI during the first half of pregnancy suggests that this isoform may serve an important role in the local production of progesterone needed either for implantation of the embryo and/or maintenance of early pregnancy.
Materials and Methods Materials
Restriction endonucleases HindIII and SspI, Taq polymerase, and RNAsin were purchased from Promega Corp. (Madison, WI). AccI and AvaII restriction enzymes were obtained from GIBCO BRL (Gaithersburg, MD), and NdeI and Sfu I restriction enzymes and AMV reverse transcriptase from Boehringer Mannheim Biochemicals (Indianapolis, IN). The SpinBind DNA Recovery System was purchased from FMC BioProducts (Rockland, ME), and the Enhanced ChemiLuminescent detection kit was purchased from Amersham Corp. (Arlington Heights, IL). RNAzol B was obtained from Cinna Biotex (Houston, TX). Diethylaminoethyl-dextran was purchased from Pharmacia LKB Biotechnology (Uppsala, Sweden; [7-N-3 H]pregnenolone (10 Ci/mmol), [1,2-N-3 H]dehydroepiandrosterone (50 Ci/mmol), [4- 14 C]progesterone (50 mCi/mmol), [4- 14 C] androstenedione (50 mCi/mmol) were purchased from Dupont (Wilmington, DE). Nonradioactive dehydroepiandrosterone and androstenedione were purchased from Steraloids (Wilmington, NH), and nonradioactive pregnenolone and progesterone were purchased from Sigma (St. Louis, MO). ITLCA SA sheets were purchased from Gelman Sciences, (Ann Arbor, MI). Mouse 7-day embryo cDNA pooled from Swiss-Webster/NIH embryos was purchased from Clontech Laboratories (Palo Alto, CA).
Animals and tissue preparation
A variety of mice were used: from Jackson Laboratory (Bar Harbor, ME), C57BLxSJL andC57BL/6J male and female mice, as well as pregnant mothers, were delivered to the University of Michigan on day 7.5 postcoitum (pc). All procedures were within the Guideline of Responsible Animal Care at the University of Michigan and had the approval of the Institutional Committee on Animal Care and Use at the University of Michigan. C57xBalb/C male and female mice were obtained from Harlan Laboratories Ltd. (Jerusalem, Israel). All experiments performed in Israel were reviewed by the Institutional Committee on Animal Care and Use of the Faculty of Science, The Institute of Life Sciences, The Hebrew University of Jerusalem and found to be compatible with the standards for care and use of laboratory animals. The C57BLxSJL or the C57xBalb/C mice were mated and the next morning examined for vaginal plugs. 1200 h was designated day 0.5 pc.
Adult mice were killed by cervical dislocation, and the appropriate tissues were removed and immediately frozen on dry ice and stored at Ϫ70 C until needed for RNA or protein extraction. Pregnant mothers were killed in the same manner at indicated times.
9.5-and 10.5-day embryos. Uterine horns were removed and placed in PBS on ice. The embryos were separated from the uterus. The 9.5-day embryos include the yolk sac and placenta. The 10.5-day embryos were separated from the yolk sac and placenta, and only the embryos were used for RNA extraction. Each embryo was frozen individually on dry ice and stored at Ϫ70 C.
Uterine tissue and giant trophoblast cells. At 4.5 days pc, uterine horns were flushed with PBS to validate the presence of blastocysts, and the entire horn was used for RNA extraction; at 6.5 days pc the isolated implantation sites were trimmed free of the muscle layers, and the stromal and decidual tissue, including the embryonic tissue, was used for RNA extraction; at 7.5 and 9.5 days pc, the implantation sites were trimmed free of the muscle layers and the embryo, and its sacs were removed. RNA was extracted from the inner layers of the giant trophoblast cells, which were carefully scraped from hemi sites and separated from the decidua basalis and decidua capsularis tissues. The latter tissues were used for RNA extraction of the typical 9.5-day decidua preparation. The giant trophoblast cells were used separately from the decidua basalis and the decidua capsularis tissue for RNA extraction.
Placentas and yolk sacs. Placentas and yolk sacs were removed from 13.5-, 15.5-, and 17.5-day embryos. Placentas were used for extraction of RNA, and yolk sacs were used for extraction of DNA for determination of gender.
RT-PCR amplification
Total RNA from the 9.5-and 10.5-day embryos and from the adult tissues was isolated using the acid-guanidinium-phenol-chloroform method (12) . RNA from uterine tissues and trophoblast cells was extracted by homogenization of these tissues in RNAzol according to the manufacturer's instruction. The concentration and purity of total RNA was determined by measuring the optical density at 260 and 280 nm. Aliquots of total RNA (at amounts indicated in the figure legends) from each mouse tissue were reverse transcribed using 25 U of AMV reverse transcriptase in 20 l total reaction. RT was performed as described in the protocol from Perkin-Elmer (Norwalk, CT), using random hexamers. Following the RT reaction, each sample (20 l) was diluted with 80 l PCR mixture (final concentrations: 2 mm MgCl 2 , 0.15 m of the appropriate primers and 2.5 U Taq polymerase) and incubated at 70 C for 5 min before PCR. Sequential cycles of amplification were performed using a Perkin-Elmer thermocycler for 35 cycles with each cycle consisting of 1 min at 95 C and 1 min at 60 C. The primer pairs (5Ј-Ͼ3Ј): for amplification of all forms of mouse 3␤-HSD: P1 (629 bp amplified product), sense CAGACCATCCTAGATGT ϩ283 to ϩ300, antisense AG-GAAGCTCACAGTTTCCA ϩ893 to ϩ911; for complete coding region of 3␤-HSD II and VI, P2 (1137 bp amplified product), sense TTCCTGT-GTTGACCATG Ϫ14 to ϩ3, antisense ATCACTGAGACGTTGTG ϩ1107 to ϩ1123; P3 (c-abl 230 bp amplified product) proto-oncogene (13), sense TTTATGGGGCAGCAGCCTGGAAAAGTACTTGGG, antisense TCACTGGGTCCAGCGAGAAGGTTTTCCTTGGAGTT. Each primer pair spans introns permitting amplified fragments of cDNA to be distinguished from any fragments derived from genomic DNA.
Identification of the RT-PCR products was established by subjecting equal aliquots of the amplified 3␤-HSD to digestion with one of five specific restriction enzymes, and the resultant fragments separated by 2% agarose gel electrophoresis and visualized by ethidium bromide staining. A few representative samples were subjected to Southern analysis using a 32 P-labeled 3␤-HSD I cDNA probe. Each analysis represents results from at least two or three separate tissue samples. Table 1 describes the size of the fragment that is diagnostic for each of the 3␤-HSD cDNAs with the indicated specific restriction enzyme. In some of the figures only the larger diagnostic fragment described in Table 1 is seen, the smaller fragment resulting from the enzyme digestion being below the sensitivity of the assay. AvaII digests both 3␤-HSD IV and V.
Southern blot analysis
RT-PCR was performed on RNA from adult skin, 9.5-day embryos, and 7.5-day pc uterine tissues. Equal aliquots of the amplified 3␤-HSD cDNA were subjected to restriction enzyme analysis as described above. The resulting DNA fragments were transferred to nylon membranes (Hybond-Nϩ, Amersham). The 3␤-HSD I cDNA with the polyA tail removed (5) was labeled with [␣-32 P] deoxycytidine 5Ј-triphosphate (New England Nuclear Radiochemicals, Boston, MA) by random hexanucleotide primer method to a specific activity of 1 ϫ 10 8 to 10 9 cpm/ g. Hybridization and washing procedures were performed as described previously (8) . 
DNA sequence analysis
For sequencing, the 1137-bp PCR product (obtained from four separate RT-PCR reactions with testis RNA using the P2 primers) was separated on 1% low melt agarose gel, eluted, and purified using the SpinBind DNA Recovery System. Both strands of the purified fragment were sequenced in the DNA Sequencing Core of the Biomedical Research Core Facilities, University of Michigan, by automated fluorescent cycle sequencing using dye labeled terminators and Applied Biosystems (Foster City, CA) instrumentation. The primers used for sequencing were synthetic oligonucleotides derived from highly conserved regions of 3␤-HSD cDNAs.
The 5Ј untranslated region of 3␤-HSD VI cDNA was deduced from a genomic clone containing the 3␤-HSD VI gene, including exons 1 and 2, which was isolated from a 129 Sv/J genomic library (Abbaszade and Payne, unpublished observations). The 5Ј region of the 3␤-HSD gene was amplified by PCR, as described above, using a T7 primer from the vector and a 3␤-HSD VI-specific primer: 5Ј-GGAGCTGCCTGGTGAC-3Ј from ϩ11 to ϩ26. Both strands of the 300-bp PCR product using the same primers were sequenced. A 132-bp exonic sequence for 5Ј untranslated region of 3␤-HSD VI cDNA was identified by homology to the sequence of the 3␤-HSD I gene (5) and identification of the consensus intron/exon splice sequences. The 3Ј untranslated sequence was determined by the 3Ј rapid amplification of cDNA ends (RACE) method (14) . Pregnant mouse uterine RNA was reversed transcribed with the adapter primer 5Ј-ACGGGCAAATTCTCCACAGCC-3Ј with added 17 dT residues. The cDNA pool was then amplified using the 3␤-HSD VI specific primer 5Ј-ACGGGCAAATTCTCCACAGCC-3Ј (ϩ643 to ϩ663) as the forward primer and the adapter primer without the poly dT. Both strands of the PCR product were sequenced from two independent clones using the same two primers. The sequence of the coding region and the 3Ј and 5Ј untranslated region obtained as described above is presented in Fig. 1 . Sequencing of the 5Ј and 3Ј untranslated sequences was performed at the DNA Sequencing Core (Protein and Nucleic Acid Biotech Facility of Stanford University) by automated dye labeled terminator sequencing.
Construction of a 3␤-HSD VI cDNA expression vector
The 1137-bp RT-PCR product (see above) obtained from testis RNA that contains the 1122-bp open reading frame of 3␤-HSD VI cDNA was subcloned into the pCR II vector using the TA Cloning Kit (Invitrogen, San Diego, CA). The resulting construct was digested with HindIII and XbaI, and the restriction fragment containing the entire coding region was inserted into identically cleaved sites in the p cytomegalovirus (CMV) 5 expression vector to yield pCMV5.3␤-HSD VI. The structure of the recombinant plasmid was verified by restriction enzyme analysis. Plasmids were purified before transfection by using the Qiagen Plasmid Purification Kit (Qiagen, Chartsworth, CA).
Transient expression of mouse 3␤-HSD cDNAs
Monkey kidney tumor (COS-7) cells were grown in DMEM (GIBCO, Grand Island, NY) supplemented with 10% calf bovine serum (Hyclone, Logan, VT). One day before transfection, cells were plated at about 1.5-2 ϫ 10 6 cells/100 mm. After 24 h incubation, medium was removed, and cells were transfected either with the pCMV5 parent vector or with pCMV5.3␤-HSD VI, I, III, IV, or V containing recombinant plasmid by the dimethylaminoethyl-dextran method. The latter four expression plasmid-transfected cells were used only for the Western blot analysis illustrated in Fig. 7 . Sixty-six hours after transfection, cells were harvested, and homogenates were prepared as previously described (3).
Measurement of 3␤-HSD activity
Enzyme activity was determined by measuring the conversion of NaOH. Before extractions of steroids, unlabeled substrate and product (150 g each) were added as carrier, and 14 C-labeled (ϳ500 cpm) product was added to each incubation tube to monitor product recovery. Steroids were extracted and separated by ITLC SA sheets in chloroform-diethyl ether (70:3) and quantified as previously described (7 
Western blot analysis
Proteins were extracted from transfected COS-7 cells, 9.5-day embryos, or testes from 50-day old mice and subjected to Western blot analysis as described previously (5-7). 3␤-HSD immunoreactive proteins were detected with a rabbit antiserum raised against the human placental 3␤-HSD and horseradish peroxidase-labeled secondary antibody using the Enhanced ChemiLuminescence kit.
Results

Isolation and identification of a new 3␤-HSD cDNA
RT-PCRs using oligonucleotide primers (P1; see Materials and Methods) designed to amplify a 629-bp fragment of all known mouse forms of 3␤-HSD cDNAs were used to determine the expression of 3␤-HSD messenger RNA (mRNA) in a number of mouse nonsteroidogenic tissues (prostate, seminal vesicles, epididymis, sebaceous glands, skin, and nonpregnant and pregnant uterus) that had not previously been examined. Among the tissues surveyed, an amplified fragment was observed only in adult skin and in the uterus during the early stages of pregnancy. To identify which of the five previously characterized 3␤-HSD cDNAs was expressed in these tissues, the cDNAs were digested with restriction enzymes specific to each of the known mouse forms. Treatment with the different enzymes did not result in smaller fragments. This finding suggested that the 3␤-HSD mRNA expressed in these tissues was the product of a new member of the mouse 3␤-HSD gene family. From the preliminary sequence of the amplified cDNA fragment, two restriction sites, NdeI and SspI, were identified that were not found in any of the previously characterized mouse 3␤-HSD cDNAs. To obtain a fragment comprising the entire coding region of this presumed new form of 3␤-HSD cDNA, primers were designed, based on the sequences of the five known 3␤-HSD cDNAs, that would amplify the complete open reading frame. Total RNA from skin and from several steroidogenic tissues was subjected to RT-PCR with these primers. One particular set of primers (P2; see Materials and Methods) was found to amplify an 1137-bp fragment both from skin and testis RNA, which when examined by restriction enzyme digestion demonstrated that these 1137-bp fragments contained both an NdeI and an SspI restriction site, but contained none of the restriction sites shown to be unique for each of the five previously identified 3␤-HSD cDNAs. The RT-PCR product amplified from testis RNA was purified and further analyzed by restriction enzyme digestion and subjected to sequencing. The 3Ј and 5Ј untranslated sequences were obtained as described in Materials and Methods. The nucleotide sequence of this newly isolated cDNA, 3␤-HSD VI, as well as the deduced amino acid sequence is presented in Fig. 1 . The sequence includes 132 bp of 5Ј untranslated sequences, 1122 bp of open reading frame encoding a protein of 373 amino acids identical to the predicted number of amino acids of the other five characterized mouse 3␤-HSD cDNAs, and the complete 375 bp 3Ј untranslated sequences including 20 bp of polyadenylated tail. The A in the first in frame ATG codon is designated as position ϩ1. The ATG codon is flanked by the eukaryotic consensus sequence for translation initiation, including the invariant purine, preferably A, in position Ϫ3 (15). Table 2 compares the percent identity of the predicted amino acid sequence of mouse 3␤-HSD VI to the predicted amino acid sequence of the other five mouse forms (7) . Data in this table show that the predicted amino acid sequence of 3␤-HSD VI is most closely related to 3␤-HSD III and II and somewhat less to 3␤-HSD I. Amino acid identity of 3␤-HSD VI to 3␤-HSD IV and V, which belong to the 3-ketosteroid reductase functional group, is considerably less.
RT-PCR was used to determine tissue-specific expression of 3␤-HSD VI mRNA using the primers described above, which yield a 629-bp fragment of all known mouse 3␤-HSD cDNAs. The identity of the amplified fragment was established by specific restriction enzyme digestion and separation of the fragments by agarose gel electrophoresis (see Table 1 ). Figure 2 indicates that the only isoform observed in skin from a male adult mouse is 3␤-HSD VI. Southern blot analysis of the gel using a 32 P-labeled 3␤-HSD I cDNA (see Materials and Methods) also did not detect any digested DNA fragments with any of the restriction enzymes tested except with the 3␤-HSD VI specific enzyme, NdeI (data not shown). We also observed expression of 3␤-HSD VI mRNA in skin of female mice and in mice homozygous for the hairless mutation h tg (16) (data not shown). Figure 3 illustrates the temporal expression of 3␤-HSD VI and I in embryonic cells during the first half of pregnancy. The only isoform observed in 7-and 9.5-day embryos was 3␤-HSD VI (Fig. 3, A and B) . These embryo samples include the yolk sac and embryonic membranes. The 10.5-day embryos that were free of placenta and yolk sac expressed 3␤-HSD VI and I (Fig. 3, C and D) . 10.5-day embryos from two different strains of mice. Figure  3C represents two different embryos from the same litter of a C57BL/6J mother; Fig. 3D is a representative gel of one of several embryos examined from a F 2 litter of C57BL/ 6JϫSJL/J parents. Expression of both 3␤-HSD VI and I was observed in 10.5-day embryos of either sex. These data indicate that 3␤-HSD VI is the earliest isoform expressed in the embryo and/or embryonic membranes, with the expression of 3␤-HSD I occurring in the embryo between days 9.5-10.5 pc.
The expression of 3␤-HSD isoforms in uterine tissue was examined at days 4.5, 6.5, and 9.5 pc and in isolated giant trophoblast cells at 9.5 days pc. As illustrated in Fig. 4A , 3␤-HSD VI is expressed as early as 4.5 days pc in the pregnant uterus, which is the time of implantation, and continues to be expressed at 9.5 days pc (Fig. 4, B and C) . No 3␤-HSD isoforms were detected in the 3.5-day pc pregnant uterus (data not shown). Illustrated in Fig. 4D is the expression of 3␤-HSD VI in giant trophoblasts at 9.5 days pc.
To ascertain whether 3␤-HSD VI is the only or the major isoform expressed in the pregnant uterus and in embryos before 10.5 days, RNA from representative samples was subjected to RT-PCR and examined by Southern blot analysis using a 32 P-labeled 3␤-HSD I cDNA as a probe (see Materials and Methods). Figure 5 shows that 3␤-HSD VI is the predominant isoform of 3␤-HSD expressed in the 9.5-day embryo (Fig. 5A ) and in uterine tissue (Fig. 5B) during the first half of mouse pregnancy with minimal expression of 3␤-HSD I.
The expression of 3␤-HSD isoforms in mouse placenta was studied at 13.5, 15.5, and 17.5 days pc. A representative gel is shown in Fig. 6 . Placentas from 13.5-day-old embryos express both 3␤-HSD VI and I, the expression of VI decreases in placentas from 15.5-day-old embryos and is no longer observed in placentas from 17.5-day-old embryos, which appear (by ethidium bromide staining) to express only 3␤-HSD I. Placentas from several embryos were examined, and the sex of the embryo was determined by PCR amplification of the male-specific gene Sry (17) . The temporal expression of the two isoforms in placenta was identical whether it came from a female or a male fetus.
Because 3␤-HSD VI was first identified in skin and testes
FIG. 2. Expression of 3␤
-HSD VI mRNA in adult mouse skin. One hundred nanogram of skin RNA from an approximately 50-day-old male C57BL/6J mouse was subjected to RT-PCR using P1 primers (see Materials and Methods). To identify type of 3␤-HSD mRNA expressed, equal aliquots of RT-PCR product were digested with restriction enzymes specific for the different forms listed in Table 1 . U, Undigested; roman numerals, specific isoforms of 3␤-HSD. The specific restriction enzyme used for identification is indicated following the isoform number: I, AccI; II, HindIII; III, SfuI; IV, AvaII; VI, NdeI. Resulting fragments were analyzed by agarose gel electrophoresis. AvaII digests both IV and V.
FIG . 3 . Expression of 3␤-HSD I and VI mRNA in developing mouse embryos. A, Two nanograms of 7-day mouse embryo cDNA (Clontech) were amplified using P1 and P3 primers (see Materials and Methods). PCR products were analyzed by enzyme digestion as described for Fig.  2 . B, Total RNA (200 ng) from 9.5-day C57BL/6J mouse embryos was analyzed as described for Fig. 2 . C, Total RNA (200 ng) from two different 10.5-day C57BL/6J mouse embryos from same litter were analyzed as described for Fig. 2 . Results represent two separate embryos. D, Total RNA (200 ng) from a 10.5-day mouse embryo (from F 2 litter of C57BL/6JϫSJL/J) was analyzed as described for Fig. 2 . from adult mice, we reexamined other tissues from adult mice for expression of 3␤-HSD VI as well as the other forms. Previously, using RNase protection analysis, we had observed only 3␤-HSD I mRNA in the classical steroidogenic tissues, the gonads, and adrenal glands (5). Figure 7 indicates that 3␤-HSD I is the only form of 3␤-HSD expressed in the adrenals of both sexes and in the ovary, whereas in the testis (using the more sensitive assay of RT-PCR) the presence of 3␤-HSD VI mRNA was detected as well as 3␤-HSD I mRNA. Examination of livers and kidneys from mature mice, which previously have been shown to express different isoforms of 3␤-HSD (5, 6, 7, 11), indicated the absence of 3␤-HSD VI expression in the adult liver and kidney of both sexes (data not shown).
To characterize the protein encoded by 3␤-HSD VI cDNA, COS-7 cells were transiently transfected with pCMV5.3␤-HSD VI, an expression vector containing the coding region of 3␤-HSD VI cDNA. The apparent molecular weight of the expressed protein was compared by Western blot analysis to transiently expressed 3␤-HSD I, III, IV, and V, as well as the endogenous isoforms expressed in the mature testis and the 9.5-day embryo. Figure 8 shows that the mobility of 3␤-HSD VI (ϳ44 kDa) is identical to, or very similar to, the mobility of 3␤-HSD III, but differs from the mobility of 3␤-HSD I, IV, and V. Figure 8 also shows that a protein of identical mobility as VI is expressed in the 9.5-day embryo and also in the testis. In the testis, as previously reported, the major expressed protein is 3␤-HSD I (ϳ42 kDa). No 3␤-HSD immunoreactive protein was observed in COS-7 cells transfected with the pCMV5 parent vector.
To characterize the enzymatic characteristics of the protein encoded by 3␤-HSD VI cDNA, cell-free homogenates of COS-7 pCMV5.3␤-HSD VI-transfected cells were first incubated with a range (0. 5 . Southern blot analysis of expression of 3␤-HSD isoforms in 9.5-day embryo (A) and 7.5-day pc pregnant uterus (B). Total RNA from 9.5-day mouse embryos (500 ng) and from 7.5-day pregnant uterus (700 ng) was analyzed as described for Fig. 2 . DNA fragments were detected by Southern blot analysis as described in Materials and Methods. Arrows, Predicted major fragment for 3␤-HSD I (455 bp) and predicted fragments for 3␤-HSD VI (461 bp and 167 bp). ϩ -dependent dehydrogenase/isomerase exhibiting very low K m values for pregnenolone.
Discussion
In this study we identified a new form of mouse 3␤-HSD, 3␤-HSD VI, which functions as an NAD ϩ -dependent dehydrogenase/isomerase. The predicted amino acid sequence 3␤-HSD VI is most closely related to the amino acid sequence of mouse 3␤-HSD III and II and somewhat less to to the amino acid sequence of 3␤-HSD I ( Table 2 ). Both 3␤-HSD III and I have previously been shown to function as NAD ϩ -requiring dehydrogenase/isomerases (10). 3␤-HSD VI exhibits very low K m values for pregnenolone (ϳ0.035 m), somewhat lower than the K m value reported for 3␤-HSD I, and markedly lower than the value reported for 3␤-HSD III (Table 3) . 3␤-HSD VI is the earliest and predominant mouse 3␤-HSD isoform expressed during the first half of pregnancy in cells of embryonic origin, and in the pregnant uterus at the time of implantation. 3␤-HSD VI continues to be expressed in placenta from 13.5-day embryos, but decreases by day 15.5, and is no longer observed at 17.5 days. Previous studies reported expression of P450 side chain cleavage (scc) mRNA at the time of implantation, and intrauterine administration of oil can mimic this effect of implantation (18) . Furthermore, P450scc (18) or 3␤-HSD mRNA (19) are not expressed before implantation. Thus, decidual expression of P450scc and 3␤-HSD VI mRNA at this time suggests that these two enzymes may be needed for local biosynthesis of progesterone during the first half of pregnancy. 3␤-HSD I mRNA was first detected in 9.5-day embryos. 3␤-HSD I is the major or only isoform expressed in gonads and adrenal glands of the mature mouse (this study; Ref. 5) . In a previous study we reported the expression of 3␤-HSD I in fetal testes as early as embryonic day 13.5 (17) and in adrenal glands of both sexes from embryonic day 15.5 and throughout development (unpublished observations). The previous studies on 3␤-HSD mRNA expression in embryonic tissues were carried out before the identification of 3␤-HSD VI. The complete digestion of the RT-PCR product from fetal testes and adrenal glands of both sexes by 3␤-HSD I-specific restriction enzymes indicates that 3␤-HSD I is the only isoform expressed in these fetal tissues.
The mouse 3␤-HSD VI cDNA appears to correspond to human 3␤-HSD I (3) and rat 3␤-HSD IV (4). These are the only isoforms in each species that are expressed in the skin. In addition, these isoforms are expressed in the placenta (3, 4) . The demonstration in this study that mouse 3␤-HSD VI is the major isoform expressed during the first half of pregnancy through day 9.5 in the uterus and embryonic cells suggests a possible role for this isoform in the local production of progesterone needed for implantation of the blastocyst and/or maintenance of early pregnancy. The failure to identify human patients lacking the orthologous enzyme, 3␤-HSD I, is consistent with the hypothesis that these forms of 3␤-HSD are required for implantation and/or maintenance of pregnancy in both rodents and humans.
The expression of 3␤-HSD VI mRNA and protein in the 50-day-old testis was unexpected. Previous reports from our laboratory examining immunoreactive proteins in Leydig cells and testes from CD-1 mice by Western analysis indicated the presence of only one immunoreactive protein with the mobility of 3␤-HSD I (5). On over exposure of these immunoblots we did observe an immunoreactive protein with a lower mobility than 3␤-HSD I (unpublished observations). In the current study, a number of testicular samples from a variety of inbred strains of mice (ϳ50 -60 days old) were examined for expression of the 3␤-HSD immunoreactive protein with lower mobility. When larger amounts of testicular protein (50 g or greater) were analyzed, this protein was detected. As shown in Fig. 8 , expression of this protein is considerably less than expression of the 3␤-HSD I protein. We also examined 3␤-HSD mRNA isoforms in MA-10 Leydig tumor cells. Both 3␤-HSD I and VI mRNA were expressed in the MA-10 Leydig cells (data not shown). This observation indicates that Leydig cells are the cell of the testis in which both 3␤-HSD VI and I are expressed. The function served by 3␤-HSD VI in the testis remains to be established. Expression of 3␤-HSD VI appears to be male specific in the gonad, because this isoform was not detected in ovaries (Fig. 7) . Recently, the expression of human 3␤-HSD type I transcripts were observed in human testes (20) . The observation that human testes as well as mouse testes express these forms of 3␤-HSD provides additional evidence that human type I and mouse type VI are orthologous. Keeney et al. (21) reported the expression in mouse testes of an immunoreactive protein with a lower mobility relative to mouse 3␤-HSD I. These authors reported that this lower mobility protein was male specific in the gonad and first appeared early during pubertal development. From Northern analysis using an oligonucleotide based on the partial sequence of the 3␤-HSD II cDNA published by our laboratory (21), Keeney et al. concluded that the lower mobility immunoreactive protein represented 3␤-HSD II. The oligonucleotide used by these authors exhibits only one mismatch out of 25 bases when compared with 3␤-HSD VI. Therefore, this oligonucleotide would not discriminate between 3␤-HSD II and VI. From the current study (Figs. 7 and 8 ) it can be concluded that this testicular 3␤-HSD isoform represents 3␤-HSD VI and not 3␤-HSD II as reported (21) .
In summary, a sixth form of the mouse 3␤-HSD multigene family, the orthologous form to human I, has been identified. The demonstration in this study that this form is expressed in the uterus at the time of implantation and in embryonic cells during the first half of pregnancy predicts a similar role for human 3␤-HSD I, and suggests that these isoforms of 3␤-HSD may be involved in the local production of progesterone that is needed for successful implantation of the blastocyst and/or maintenance of early pregnancy. The mouse is an ideal model for testing the functional role of 3␤-HSD VI by analysis of targeted mutations of mouse 3␤-HSD VI.
